Literature DB >> 18805735

Malaria: some considerations regarding parasite productivity.

Ronald Rosenberg1.   

Abstract

The complicated life cycle of Plasmodium is characterized by proliferative stages in each of its hosts--mosquito and vertebrate--that are interrupted by restrictive steps as it moves from one to the other. Productivity at each stage affects not only pathology but also the probability for successful transmission. This Opinion article briefly assesses what is known about productivity at each step and attempts, with limited success, to put each in the context of an entire cycle, sporozoite to sporozoite.

Entities:  

Mesh：

Year:  2008        PMID： 18805735     DOI： 10.1016/j.pt.2008.07.009

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN： 1471-4922


  23 in total

1.  Identification of three ookinete-specific genes and evaluation of their transmission-blocking potentials in Plasmodium berghei.

Authors:  Wenqi Zheng; Xu Kou; Yunting Du; Fei Liu; Chunyun Yu; Takafumi Tsuboi; Qi Fan; Enjie Luo; Yaming Cao; Liwang Cui
Journal:  Vaccine       Date:  2016-04-12       Impact factor: 3.641

Review 2.  Mitosis in the human malaria parasite Plasmodium falciparum.

Authors:  Noel Gerald; Babita Mahajan; Sanjai Kumar
Journal:  Eukaryot Cell       Date:  2011-02-11

Review 3.  New insight-guided approaches to detect, cure, prevent and eliminate malaria.

Authors:  Sushil Kumar; Renu Kumari; Richa Pandey
Journal:  Protoplasma       Date:  2014-10-17       Impact factor: 3.356

4.  Evaluation of Plasmodium vivax HAP2 as a transmission-blocking vaccine candidate.

Authors:  Yue Qiu; Yan Zhao; Fei Liu; Bo Ye; Zhenjun Zhao; Sataporn Thongpoon; Wanlapa Roobsoong; Jetsumon Sattabongkot; Liwang Cui; Qi Fan; Yaming Cao
Journal:  Vaccine       Date:  2020-02-21       Impact factor: 3.641

Review 5.  Ivermectin: a complimentary weapon against the spread of malaria?

Authors:  Haoues Alout; Brian D Foy
Journal:  Expert Rev Anti Infect Ther       Date:  2016-12-29       Impact factor: 5.091

6.  Transmission-blocking interventions eliminate malaria from laboratory populations.

Authors:  A M Blagborough; T S Churcher; L M Upton; A C Ghani; P W Gething; R E Sinden
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 7.  Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common.

Authors:  Nicholas J White; Li Guo Qiao; Gao Qi; Lucio Luzzatto
Journal:  Malar J       Date:  2012-12-14       Impact factor: 2.979

8.  Immunisation against a serine protease inhibitor reduces intensity of Plasmodium berghei infection in mosquitoes.

Authors:  Andrew R Williams; Sara E Zakutansky; Kazutoyo Miura; Matthew D J Dicks; Thomas S Churcher; Kerry E Jewell; Aisling M Vaughan; Alison V Turner; Melissa C Kapulu; Kristin Michel; Carole A Long; Robert E Sinden; Adrian V S Hill; Simon J Draper; Sumi Biswas
Journal:  Int J Parasitol       Date:  2013-07-18       Impact factor: 3.981

9.  A comparison of Plasmodium falciparum circumsporozoite protein-based slot blot and ELISA immuno-assays for oocyst detection in mosquito homogenates.

Authors:  Will Stone; Bryan Grabias; Kjerstin Lanke; Hong Zheng; Emily Locke; Diadier Diallo; Ashley Birkett; Merribeth Morin; Teun Bousema; Sanjai Kumar
Journal:  Malar J       Date:  2015-11-14       Impact factor: 2.979

Review 10.  Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria.

Authors:  Nicholas J White; Elizabeth A Ashley; Judith Recht; Michael J Delves; Andrea Ruecker; Frank M Smithuis; Alice C Eziefula; Teun Bousema; Chris Drakeley; Kesinee Chotivanich; Mallika Imwong; Sasithon Pukrittayakamee; Jetsumon Prachumsri; Cindy Chu; Chiara Andolina; Germana Bancone; Tran T Hien; Mayfong Mayxay; Walter R J Taylor; Lorenz von Seidlein; Ric N Price; Karen I Barnes; Abdoulaye Djimdé; Feiko ter Kuile; Roly Gosling; Ingrid Chen; Mehul J Dhorda; Kasia Stepniewska; Philippe Guérin; Charles J Woodrow; Arjen M Dondorp; Nicholas P J Day; Francois H Nosten
Journal:  Malar J       Date:  2014-12-09       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.